Xinhua Pharmaceutical (000756.SZ) obtained the drug registration certificate for Magnesium Sulfate, Sodium Sulfate, and Potassium Sulfate Oral Concentrated Solution.

Zhito Finance APP News: Xinhua Pharmaceutical (000756.SZ) announced that recently, the company received the "Drug Registration Certificate" for Magnesium Sulfate, Sodium Sulfate, and Potassium Sulfate Oral Concentrated Solution (hereinafter referred to as "this product") approved and issued by the National Medical Products Administration. This product is suitable for adults and is used for bowel cleansing before any procedure requiring a clean bowel (such as procedures requiring bowel visualization, including endoscopy, radiological examinations, and surgery).